"On that sunny March morning, in a small health center in Lobamba, a rural area of Eswatini, this 32-year-old sex worker has just become one of the first people in the world to receive lenacapavir, a drug that, administered twice a year, offers nearly 100% protection against HIV."
"Eswatini, because of its small size and the progress it is already making in prevention, is a perfect place to start seeing results. And I think the world desperately needs a positive story related to HIV."
"Precious doesn't know it, but the commercial price of the injection she just received exceeds $11,600, an amount that must be doubled to calculate the annual cost per person."
Precious, a 32-year-old sex worker in Eswatini, receives lenacapavir, a drug providing nearly 100% protection against HIV. Eswatini has a 26% HIV prevalence rate, making it a pioneer in lenacapavir distribution. The drug could eliminate HIV as a public health threat by 2030. The Global Fund emphasizes the importance of positive stories related to HIV. The commercial price of the injection exceeds $11,600 annually, highlighting health equity issues.
Read at english.elpais.com
Unable to calculate read time
Collection
[
|
...
]